Clinical Trial Update: Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer

View source ↗

Summary

This clinical trial update describes a pilot trial of a HER-2/Neu pulsed DC1 vaccine in patients with HER-2 positive metastatic cancer, noting that the trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• HER-2/Neu Pulsed DC1 Vaccine

Snippet

Sponsor: University of Pennsylvania | Conditions: Metastatic Cancer | Status: NO_LONGER_AVAILABLE